Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

Optionable: Yes  Market Cap: 392 M  90-day average vol: 149,297

Previous close: 9.69  Open: 9.69  Bid: 9.55  Ask: 10.47
52 week range    
ADM / 
ZTS / 
MRK / 
Last updated: Thursday 30th November 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)


0.021142 B15.775.98


1 B509.6133.32


0 B8158.065


0.0161238 B37.4243.55


0.0356207 B28.877.58


0.006594 B48.1200.32

PAHC Income Statement

Amortization-5 M-6 M-7 M-7 M-7 M-7 M-10 M-10 M10 M10 M
Amortization of intangibles-5 M-5 M-6 M-6 M-6 M-6 M-9 M-9 M9 M10 M
Basic EPS from continuing operations1.210.81
Basic EPS total-0.11.552.111.631.611.350.831.341.210.81
Basic weighted shares outstanding32193.039 M39 M39524.040181.040412.040454.040 M41 M41 M
Cost of sales-487 M-515 M-512 M-516 M-553 M-563 M-543 M-562 M657 M680 M
Depreciation-21 M-22 M-23 M-26 M-27 M-28 M-32 M-32 M33 M34 M
DepreciationAndAmortization-21 M-22 M-23 M-26 M-27 M-28 M-32 M-32 M33 M34 M
Diluted EPS total-0.11.512.071.611.611.350.831.341.210.81
Diluted normalized net income/share1.210.81
Diluted weighted shares outstanding32193.040 M40 M40042.040385.040523.040504.041 M41 M41 M
Dividends paid per share0.820.
Earnings from equity interest16 M16 M16 M19 M
EarningsFromEquityInterestNetOfTax16 M16 M16 M19 M
GainOnSaleOfBusiness-2 M
GainOnSaleOfSecurity-2 M1 M
GeneralAndAdministrativeExpense-7 M-7 M-8 M-8 M-33 M-38 M-10 M-10 M206 M226 M
Gross operating profit204 M233 M239 M248 M267 M265 M257 M271 M285 M298 M
ImpairmentOfCapitalAssets-2 M-2 M-1 M-1 M-1 M1 M1 M
Income before tax6 M79 M77 M81 M88 M72 M56 M66 M72 M54 M
Income restructuring and M&A-613000.0-1 M-1 M-1 M-425000.0
Income taxes9 M18 M-6 M16 M23 M17 M22 M12 M23 M21 M
Interest income119000.0-249000.0256000.02 M2 M2 M2 M838000.0816000.03 M
InterestExpenseNonOperating33 M-15 M-17 M-17 M-14 M-14 M-15 M-14 M12 M15 M
MiscOtherSpecialCharges-23 M-3 M820 M828 M
Net income from total operations-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetIncomeCommonStockholders-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetIncomeContinuousOperations-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetNonOperatingInterestIncomeExpense-33 M14 M17 M-15 M12 M-12 M-13 M-13 M-12 M-15 M
NetOperatingInterestIncomeExpense33 M-14 M-17 M-15 M-12 M-12 M-13 M-13 M
Normalized income47 M
Operating income64 M88 M86 M98 M-721 M83 M69 M75 M79 M72 M
Operating income before depreciation (EBITDA)62 M87 M84 M91 M102 M86 M74 M85 M117 M104 M
OperatingExpense144 M146 M153 M150 M168 M181 M188 M197 M206 M226 M
Other income net23 M-521000.0-17 M3 M-820 M-2 M-428000.0-264000.0-1 M3 M
OtherGandA-7 M-7 M-8 M-8 M-33 M-38 M-10 M-10 M206 M226 M
OtherImpairmentOfCapitalAssets-2 M
OtherOperatingExpenses-7 M-3 M-8 M-1 M-2 M-6 M-11 M-8 M-5 M-2 M
OtherWriteOff226000.0-67000.0-96000.0-122000.0-2 M-428000.0-264000.0180000.03 M
RentAndLandingFees-7 M-7 M-8 M-8 M-8 M-9 M
Research & development expense-8 M-10 M-11 M-9 M-10 M-12 M-14 M-18 M21 M24 M
ResearchExpense21 M24 M
RestructringAndMnAIncome-613000.0-1 M-1 M-1 M-425000.0
SalariesAndWages-3 M-4 M-4 M-2 M-334000.0-2 M-2 M-1 M-1 M705000.0
Selling Gen & administrative expense144 M146 M153 M150 M168 M181 M188 M197 M206 M226 M
SellingAndMarketingExpense144 M146 M153 M150 M168 M181 M188 M197 M
SellingExpense144 M146 M153 M150 M168 M181 M188 M197 M
Special income/charges613000.01 M4 M3 M1 M1 M1 M-1 M-1 M
Total Income available for interest expense (EBIT)39 M64 M60 M64 M74 M58 M41 M53 M84 M69 M
Total common shares outstanding39 M39 M39 M40 M40 M40 M40 M41 M41 M41 M
Total net income-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
Total ordinary shares20 M20 M20 M20 M20 M20 M20 M20 M20 M20 M
Total revenues692 M749 M752 M764 M820 M828 M800 M833 M942 M978 M
TotalExpenses-344 M-370 M-359 M-366 M-385 M-382 M-356 M-365 M863 M906 M
TotalRevenue692 M749 M752 M764 M820 M828 M800 M833 M942 M978 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today